Clinical Trials
3 trialsNCT00084487 2014-05-23
Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00006262 2012-06-11
Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer
Northwestern University
Phase 2 Terminated
NCT00005997 2010-06-11
Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated